Bradford Walters, MD, PhD, MBA, a prominent neurosurgeon with extensive clinical research and pharmaceutical experience, joined RTI Health Solutions (RTI-HS) in October as Senior Director of Clinical and Medical Services.
“We are very excited to welcome Brad to our clinical research and consulting team,” said Allen Mangel, Senior Vice President of RTI-HS. “With his previous positions as a clinician, researcher, and business leader, Brad brings a unique and impressive combination of experience to RTI-HS and our clients.”
“I welcome the opportunity to join such a distinguished team of scientists and consultants,” said Walters. “I look forward to contributing to the growth and expansion of RTI-HS’ broad range of clinical research activities, both in the mid- to later-stage areas for which they have become so well known and as well in the earlier stages of pharmaceutical development.”
First earning an AB in Chemistry and Physics at Harvard, Walters then earned a PhD in Anatomy and Embryology at the University of London and an MD from Harvard Medical School. Upon completing his advanced degrees, Walters completed a surgical internship at John Hopkins Hospital and neurological surgery residency at Massachusetts General Hospital where he later became Chief Resident in Neurosurgery.
Walters later joined the faculty at the University of North Carolina (UNC) School of Medicine at Chapel Hill, where he was a tenured professor and established the radiosurgery and epilepsy surgery programs with colleagues from radiation oncology and neurology, respectively. Walters then earned an MBA from the Kenan-Flagler Business School.
After earning his MBA, Walters was first a Principal and then Partner at Academy Funds, a North Carolina-based venture capital firm specializing in spinouts of university technologies. While at Academy Funds, he served on the Boards of Directors for Kucera Pharmaceutical Company, ParinGenix, and Curry Pharmaceutical—all Academy Funds portfolio companies. Walters is also the current Acting President and CEO of Kucera. Additionally, for the past two years, Walters has been an independent life sciences consultant focusing on Phase I and II trials.
Throughout his career, Walters has remained active in the medical community. He has held various appointments with the North Carolina Healthcare Information and Communications Alliance, North Carolina Medical Society, North Carolina Biotechnology Center Strategic Plan: Building Entrepreneurial Companies Workgroup, Governor’s Task Force on Nanotechnology and North Carolina’s Economy, Piedmont Triad Entrepreneurial Network, Science Advisory Board at UNC-Greensboro, and Institutional Review Board at UNC-Chapel Hill, among others. Further, Walters has often been an invited speaker at medical and venture capital conferences and has numerous publications in peer-reviewed journals (including Brain Research, Nature, and Stroke) and other conference proceedings.
About RTI Health Solutions
RTI Health Solutions provides scientifically rigorous research and consulting service in health economics, health outcomes, psychometrics, pricing and reimbursement, health preference assessment, epidemiology, pharmacovigilance, clinical development, and biostatistics to help biopharmaceutical companies successfully develop and gain market approval for their products.